Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Questex Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Questex Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
extended-release
Pharma
MHRA raises concerns with switching between long-acting drugs
The notice relates to long-acting ADHD therapies from companies including Johnson & Johnson, Novartis and Takeda.
Nick Paul Taylor
Sep 27, 2022 7:05am
Targeting $500M market, Amneal files for Parkinson's approval
Sep 2, 2022 7:55am
Advanz bags EU rights to Polypid's prolonged-release antibiotic
Aug 9, 2022 9:54am
Avadel gets tentative FDA nod for rival to Jazz narcolepsy drug
Jul 26, 2022 7:50am
Dr. Reddy's launches extended-release rival to $200M Pfizer drug
Jul 11, 2022 12:06pm
Sanofi offloads rights to prolonged-release antipsychotic drug
Apr 26, 2022 10:18am
